Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

IgG antibody response to Mycobacterium tuberculosis curli pili (MTP) in people from different geographical regions in Sub-Saharan Africa.
Pillay, K; Coetzer, T; Connolly, C; Pillay, B; Chiliza, T; Naidoo, K; SUTHERLAND, J; Ndung'u, T; Mayanja-Kizza, H; Pillay, M;
2025
Tuberculosis (Edinburgh, Scotland), (2025).152, 10.1016/j.tube.2025.102634.
A roadmap for integrating nutritional assessment, counselling, and support into the care of people with tuberculosis.
Sinha, P; Bhargava, M; Carwile, ME; Dauphinais, MR; Tisile, P; Cintron, C; Locks, LM; Hauser, J; Oliver, M; Heysell, SK; Mehta, S; Finkelstein, JL; Koura, KG; Cegielski, JP; HOUBEN, RM G J; MCQUAID, CF; Bhargava, A;
2025
The Lancet. Global health, (2025).13 5 10.1016/S2214-109X(25)00021-X.
World TB Day 2025 Theme "Yes! We Can End TB: Commit, Invest, Deliver" can be made a reality through concerted global efforts to advance diagnosis, treatment and research of tuberculosis infection and disease.
Goletti, D; Matteelli, A; CLIFF, JM; Meintjes, G; Graham, S; Esmail, H; Shan Lee, S;
2025
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, (2025).155, 10.1016/j.ijid.2025.107892.
Primary efficacy endpoints in phase 3 non-inferiority trials to establish new tuberculosis treatment regimens should only include microbiological outcomes.
Yates, TA; GRINT, DJ;
2025
The Lancet microbe, (2025).6 7 10.1016/j.lanmic.2025.101117.
Urgent request for pretomanid label expansion to align with WHO guidelines and improve treatment accessibility and efficacy.
Kuksa, L; Andrejak, C; Haecker, B; Bothamley, G; Calcagno, A; Cirillo, DM; Duarte, R; Fatima, R; Ferlazzo, G; Guglielmetti, L; Günther, G; Hewison, C; Horsburgh, CR; Jäger, T; Kalancha, Y; Otto-Knapp, R; KRANZER, K; Lillebaek, T; Marks, G; Middelkoop, K; Motta, I; Rabinova, V; Sommerfeld, P; Tattevin, P; Lange, C;
2025
IJTLD open, (2025).2 3 10.5588/ijtldopen.25.0152.
Effect of digital adherence technologies on treatment outcomes in people with drug-susceptible tuberculosis: four pragmatic, cluster-randomised trials.
Jerene, D; Van Kalmthout, K; Levy, J; Alacapa, J; Deyanova, N; Dube, T; Mganga, A; Tasca, B; Bogdanov, A; Efo, E; Gamazina, K; Garfin, AM C; Kochanov, V; Leung, A; Madden, N; Maraba, N; MCQUAID, CF; Mleoh, L; Onjare, B; Powers, R; Terleiva, Y; Van Rest, J; Gebhard, A; FIELDING, K; Charalambous, S;
2025
Lancet (London, England), (2025).405 10485 10.1016/S0140-6736(24)02847-2.
Efficacy of BCG vaccination on incidence, severity and clinical progression of COVID-19: A BCG-REVAC population analysis.
De Souza, RA; Barreto, FR; De Jesus Lima, CC O; Da Natividade, MS; De Souza Teles Santos, CA; Ichihara, MY; Pereira, M; De Castro, DB; Genser, B; RODRIGUES, LC; Barreto, ML; Pereira, SM;
2025
Vaccine, (2025).54, 10.1016/j.vaccine.2025.126911.
Scaling-up symptom-agnostic, community-wide screening toward global tuberculosis elimination: opportunities, challenges, and lessons from history.
Esmail, H; Miller, C; Falzon, D; De Vries, G; Chijioke-Akaniro, O; HORTON, KC; Kohli, M; Dharmapuri Vachaspathi, T; Vo, LN Q; Zaidi, SM A; Squire, SB; Coussens, AK; HOUBEN, RM G J;
2025
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, (2025).155, 10.1016/j.ijid.2025.107875.
Host-directed therapy in diabetes and tuberculosis comorbidity toward global tuberculosis elimination.
Smith, SG; Bowness, R; CLIFF, JM;
2025
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, (2025).155, 10.1016/j.ijid.2025.107877.
Tissue-specific T cell profiles in Mycobacterium tuberculosis uninfected IGRA negative and positive individuals.
Ahimbisibwe, G; Nakibuule, M; SSEJJOBA, MM; Bisoboka, CP; Akello, FG; Turyasingura, MJ; Mulwana, R; Nabulime, J; Babirye, F; Kizito, MA; Lekuya, HM; Adakun, AS; Nalumansi, D; Muryasingura, S; Lukande, R; Baluku, JB; Biraro, IA; COSE, S;
2025
Frontiers in Tuberculosis, (2025).3, 10.3389/ftubr.2025.1535945.